Patents by Inventor S. Peter Klinken

S. Peter Klinken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transcription factor modulator
    Patent number: 8778633
    Abstract: The present invention relates to novel agents that are useful for modulating transcription factor activity. In particular, the present invention relates to a transcription factor modulator comprising (i) a pharmaceutically-effective amount of a HLS-5 polypeptide, isoform thereof, functional fragment thereof or pharmaceutical composition thereof or (ii) a compound or composition capable of regulating the endogenous levels of HLS-5 or its activity; or (iii) combinations thereof.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: July 15, 2014
    Assignee: Molecular Discover Systems
    Inventors: Jean-Philippe Lalonde, Robin Scaife, S. Peter Klinken
  • Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
    Publication number: 20140127234
    Abstract: The present invention relates to novel agents that are useful for treating hormone-dependent disorders. In particular, the present invention relates to A method of modulating a nuclear receptor in vivo comprising the step of administering to a subject in need thereof nuclear receptor modulating agent comprising a compound or composition capable of altering the endogenous levels of HLS-5 or its activity.
    Type: Application
    Filed: July 31, 2013
    Publication date: May 8, 2014
    Inventors: S. Peter Klinken, Jean-Philippe Lalonde
  • Sumoylation Control Agent and Uses Thereof
    Publication number: 20130330738
    Abstract: The present invention relates to novel agents that are useful for controlling sumoylation. In particular, the present invention relates to a sumoylation control agent comprising: (i) a pharmaceutically-effective amount of a HLS-5 polypeptide, isoform thereof, functional fragment thereof, or a pharmaceutical composition thereof; or (ii) a compound or composition capable of modulating the endogenous levels of HLS-5 or its activity; or (iii) combinations thereof.
    Type: Application
    Filed: June 4, 2013
    Publication date: December 12, 2013
    Applicant: Molecular Discovery Systems
    Inventors: S. Peter Klinken, Jean-Philippe Lalonde, Raelene Lim, Robin Scaife, Sam Gallagher
  • Transcription Factor Modulator
    Publication number: 20120164658
    Abstract: The present invention relates to novel agents that are useful for modulating transcription factor activity. In particular, the present invention relates to a transcription factor modulator comprising (i) a pharmaceutically-effective amount of a HLS-5 polypeptide, isoform thereof, functional fragment thereof or pharmaceutical composition thereof or (ii) a compound or composition capable of regulating the endogenous levels of HLS-5 or its activity; or (iii) combinations thereof.
    Type: Application
    Filed: December 2, 2011
    Publication date: June 28, 2012
    Inventors: Jean-Philippe Lalonde, Robin Scaife, S. Peter Klinken
  • Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
    Publication number: 20100215637
    Abstract: The present invention relates to novel agents that are useful for treating hormone-dependent disorders. In particular, the present invention relates to A method of modulating a nuclear receptor in vivo comprising the step of administering to a subject in need thereof A nuclear receptor modulating agent comprising a compound or composition capable of altering the endogenous levels of HLS-5 or its activity.
    Type: Application
    Filed: March 28, 2007
    Publication date: August 26, 2010
    Applicant: Biopharmica Ltd
    Inventors: S. Peter Klinken, Jean-Phillippe Lalonde
  • Sumoylation Control Agent and Uses Thereof
    Publication number: 20100048450
    Abstract: The present invention relates to novel agents that are useful for controlling sumoylation. In particular, the present invention relates to a sumoylation control agent comprising: (i) a pharmaceutically-effective amount of a HLS-5 polypeptide, isoform thereof, functional fragment thereof, or pharmaceutical composition thereof; or (ii) a compound or composition capable of modulating the endogenous levels of HLS-5 or its activity; or (iii) combinations thereof.
    Type: Application
    Filed: October 6, 2006
    Publication date: February 25, 2010
    Inventors: S. Peter Klinken, Jean-Philippe Lalonde, Raelene Lim, Robin Scaife, Sam Gallagher
  • Transcription Factor Modulator
    Publication number: 20090258827
    Abstract: The present invention relates to novel agents that are useful for modulating transcription factor activity. In particular, the present invention relates to A transcription factor modulator comprising (i) a pharmaceutically-effective amount of a HLS-5 polypeptide, isoform thereof, functional fragment thereof or pharmaceutical composition thereof; or (ii) a compound or composition capable of regulating the endogenous levels of HLS-5 or its activity; or (iii) combinations thereof.
    Type: Application
    Filed: April 5, 2007
    Publication date: October 15, 2009
    Applicant: BIOPHARMICA LTD.
    Inventors: Jean-Philippe Lalonde, Robin Scaife, S. Peter Klinken